Transcatheter aortic valve replacement: does timing of cardiac implantable electronic device implantation impact mortality?
J Interv Card Electrophysiol
.
2022 Oct;65(1):3-5.
doi: 10.1007/s10840-022-01286-x.
Epub 2022 Jun 27.
Authors
Luai Madanat
1
,
Elizabeth Seeley
2
,
Kuldeep Shah
3
,
Ramy Mando
3
,
Ivan Hanson
3
,
Amr Abbas
3
,
Brian M Renard
3
,
David E Haines
3
,
Nishaki Mehta
4
5
6
Affiliations
1
Department of Internal Medicine, William Beaumont Hospital, Royal Oak, MI, USA.
2
Oakland University William Beaumont School of Medicine, Rochester, MI, USA.
3
Department of Cardiovascular Medicine, William Beaumont Hospital, Royal Oak, MI, USA.
4
Department of Cardiovascular Medicine, William Beaumont Hospital, Royal Oak, MI, USA. Nishaki.Mehta@beaumont.org.
5
Oakland University School of Medicine, Rochester, MI, USA. Nishaki.Mehta@beaumont.org.
6
Adjunct Faculty, University of Virginia, Charlottesville, VA, USA. Nishaki.Mehta@beaumont.org.
PMID:
35759161
DOI:
10.1007/s10840-022-01286-x
No abstract available
Publication types
Letter
MeSH terms
Aortic Valve / surgery
Aortic Valve Stenosis* / surgery
Electronics
Heart Valve Prosthesis*
Humans
Risk Factors
Transcatheter Aortic Valve Replacement*
Treatment Outcome